Position in NRIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,253,456
+$8,009,234 QoQ
Shares Held
876,070
+2.5% QoQ
Ownership
0.844%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. NRIX ranks #73 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,253,456 | 876,070 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $13,244,222 | 854,466 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $15,283,785 | 805,682 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $6,283,280 | 680,009 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,443,739 | 653,533 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,319,763 | 700,317 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,430,404 | 659,788 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $12,737,230 | 566,855 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $9,142,916 | 438,089 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,938,946 | 404,010 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,301,519 | 416,814 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,465,094 | 440,852 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,282,132 | 428,642 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,552,159 | 400,018 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,479,212 | 407,943 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,260,756 | 403,742 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,918,416 | 388,194 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,266,561 | 304,537 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,148,806 | 316,021 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $9,617,339 | 321,006 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,876,490 | 296,890 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,233,926 | 232,677 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,531,256 | 137,812 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,654,828 | 133,338 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||